US Map / Rhode Island
State RI

Clinical Trials in Rhode Island

Recruiting clinical trials with at least one study location in Rhode Island. Data updated daily from ClinicalTrials.gov.

Total Trials
85
Recruiting Now
85
← Back to US Map
Top Conditions in Rhode Island
Malignant Solid Neoplasm (3)Acute Myeloid Leukemia (3)Alcohol Use Disorder (3)Alzheimer Disease (2)Acute Lymphoblastic Leukemia (2)Pregnancy (2)Pulmonary Hypertension (2)Head and Neck Neoplasms (2)Acute Stress Disorder (2)Ulcerative Colitis (2)Opioid Use Disorder (2)Mild Cognitive Impairment (2)
NCT07036640 N/A
Recruiting
The Impact of Acute Exercise in the Heat on Breast Milk Production and Compositi...
Condition
Lactation
Enrollment
10 pts
Location
United States
Sponsor
Providence College
View Trial →
NCT07446374 N/A
Recruiting
Rhode Island Community-based Maternal Support Services
Condition
Perinatal Outcomes
Enrollment
3,000 pts
Location
United States
Sponsor
Women and Infants Hospital of
View Trial →
NCT06974604 Phase 2
Recruiting
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-...
Condition
Breast Neoplasms
Enrollment
60 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT07024784 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Partici...
Condition
Gynecologic Cancers
Enrollment
377 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
View Trial →
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT06494488 EARLY_Phase 1
Recruiting
Differential Thrombogenesis by EPA and DHA Mediated by HDL
Condition
Lipid Metabolism Disorders
Enrollment
80 pts
Location
United States
Sponsor
The Miriam Hospital
View Trial →
NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Condition
Acute Leukemias
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT07197476 N/A
Recruiting
Adolescent Stress and Substance Intervention Subsequent to Trauma
Condition
PTSD
Enrollment
62 pts
Location
United States
Sponsor
Rhode Island Hospital
View Trial →
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
View Trial →
Page 4 of 4 — 85 trials total
← Prev